Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

E-Cigarettes tested as a safer alternative for asthmatic smokers

NCT ID NCT05278065

First seen Nov 18, 2025 · Last updated Jun 23, 2026 · Updated 27 times

Summary

This study gave free e-cigarettes to 17 adult smokers with asthma for 8 weeks to see if they would smoke fewer regular cigarettes and have better lung function. Researchers measured changes in smoking habits, dependence, and asthma symptoms. The goal was to gather early information on whether e-cigarettes could reduce harm in this group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Center for Alcohol and Addiction Studies

    Providence, Rhode Island, 02903, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

electronic cigarette with 5% nicotine e-liquid

What this could lead to

If it works, this could point toward a way to help smokers with asthma cut down on cigarettes and possibly improve their lung function.

What could go wrong

This was a very small study (17 people) with no control group, so results may not apply widely. The long-term safety of e-cigarettes is still unknown.

Conditions

The condition(s) this trial relates to.

asthma Cigarette Smoking Harm Reduction Smoking Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.